论文部分内容阅读
采用淋巴因子激活的杀伤细胞治疗妇科恶性肿瘤14例。方法:每周输入淋巴因子激活的杀伤细胞2次,每疗程6次,平均每次输入的细胞数为2.64×108。每次输注淋巴因子激活的杀伤细胞时,均在其悬液中加入10万U白细胞介素-2。结果:2例卵巢癌腹水消失。可观察癌灶变化的6例中,1例部分有效,2例稳定,3例发展。检测治疗前后LAK(淋巴因子激活的杀伤细胞)、NK(自然杀伤细胞)、CD4(T辅助细胞)均显著升高(P<0.01),CD3(总T细胞)和淋转明显升高(P<0.05)。84次(14例)输注中26次(11例)出现中度发热反应。1例诱发心肌梗塞。
Lymphokine-activated killer cells were used to treat 14 cases of gynecological malignancies. METHODS: Lymphokine-activated killer cells were injected twice a week for 6 cycles, with an average of 2.64 × 108 cells per input. Each time lymphocyte activated killer cells were infused, 100,000 U of interleukin-2 was added to the suspension. Results: Ascites disappeared in 2 cases of ovarian cancer. Of the 6 cases with observable lesion changes, 1 was partially effective, 2 stable, and 3 developed. LAK (lymphokine activated killer cells), NK (natural killer cells), and CD4 (T helper cells) were significantly elevated before and after treatment (P<0.01), and CD3 (total T cells) and lymphopenia were significantly increased. (P<0.05). Twenty-six (11) of the 84 (14) infusions had moderate fever. One case induced myocardial infarction.